Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

An initiative aimed at raising student achievement doesn't give students enough practice with foundational skills, some say.

Alumis is also developing another tyrosine kinase 2 blocker, A-005, for neuroinflammatory and neurodegenerative conditions ...

The two biotechs, which have lost most of their share value following lucrative IPOs, are combining in a deal that leaves the ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Nintendo’s latest earnings report is out and sales of the Switch console have plummeted after the Switch 2 rumors and ...

New York City public schools are updating a controversial math curriculum after the teachers union raised concerns about a ...

A change in the admissions process for the Monroe Advanced Technical Academy has resulted in a surge of new applicants this ...

Administrators at Hayes High School reported Tuesday the school’s new standards-based grading has increased the school’s performance index and drastically reduced failures.

A one-time scholarship will be offered in memory of Donna Marie Van Holla to an Iron Mountain High School graduate. Van Holla ...

A Westwood Middle School educator of 14 years was named the division teacher of the year for Danville Public Schools last ...